Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
48.05
-0.20 (-0.41%)
Feb 28, 2025, 4:00 PM CST

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Feb '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
20,06817,23719,53016,03014,959-
Upgrade
Market Cap Growth
-11.74%-11.74%21.84%7.16%--
Upgrade
Enterprise Value
20,17217,34218,89114,51814,805-
Upgrade
Last Close Price
48.0541.4747.8539.3737.01-
Upgrade
PS Ratio
55.1847.83213.94-1454.37-
Upgrade
PB Ratio
46.6239.4223.019.126.07-
Upgrade
P/TBV Ratio
--50.5112.667.52-
Upgrade
EV/Sales Ratio
55.9748.12206.93-1439.37-
Upgrade
Debt / Equity Ratio
2.072.070.480.050.04-
Upgrade
Asset Turnover
--0.05-0.010.03
Upgrade
Inventory Turnover
--0.54---
Upgrade
Quick Ratio
--1.785.709.825.88
Upgrade
Current Ratio
--2.035.939.966.06
Upgrade
Return on Equity (ROE)
-133.26%-133.26%-84.98%-34.87%-37.83%-76.72%
Upgrade
Return on Assets (ROA)
---40.35%-20.52%-21.46%-52.76%
Upgrade
Return on Capital (ROIC)
-45.77%-45.77%-46.54%-22.54%-23.23%-62.42%
Upgrade
Earnings Yield
-4.27%-4.97%-5.67%-4.59%-4.48%-
Upgrade
FCF Yield
--5.12%-4.22%-3.35%-
Upgrade
Buyback Yield / Dilution
-1.63%-1.63%-0.70%-12.29%-0.07%-
Upgrade
Total Shareholder Return
-1.63%-1.63%-0.70%-12.29%-0.07%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.